Prognostic Impact of Hyperglycemia in Nondiabetic and Diabetic Patients With ST-Elevation Myocardial Infarction
- 1 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 5 (6) , 708-718
Abstract
Background—: Hyperglycemia on admission is associated with increased mortality rates in patients with ST-elevation myocardial infarction (STEMI). However, data regarding the relationship between hyperglycemia and myocardial damage in STEMI are scarce. The aim of this study was to determine the relationship of diabetes mellitus status and hyperglycemia on myocardial damage assessed by cardiovascular magnetic resonance imaging and to evaluate the long-term prognostic significance of hyperglycemia in a high-risk STEMI population. Methods and Results—: Glucose levels were determined on admission in 411 consecutive STEMI patients reperfused by primary angioplasty. Patients were categorized on the basis of diabetes mellitus status and admission glucose level. Magnetic resonance imaging was performed for assessment of infarct size and microvascular obstruction. The primary clinical end point was the occurrence of major adverse cardiovascular events at long-term follow-up. STEMI patients with pre-existing diabetes mellitus were at greater risk for major adverse cardiovascular events (32% versus 11%; P P <0.001). In nondiabetic patients, the risk of severe myocardial injury started to rise once admission glucose exceeded 7.8 mmol/L, whereas the threshold was higher among patients with diabetes mellitus (≥11.1 mmol/L). Conclusions—: The higher mortality rate in diabetic versus nondiabetic STEMI patients is not explained by more pronounced myocardial damage. Hyperglycemia on admission is associated with greater myocardial injury and an increased risk of major adverse cardiovascular events at long-term follow-up. However, hyperglycemia has a stronger relationship to myocardial injury in nondiabetic compared with diabetic patients.Keywords
This publication has 38 references indexed in Scilit:
- Glucose-Lowering Targets for Patients With Cardiovascular DiseaseCirculation, 2010
- Fasting Glucose in Acute Myocardial InfarctionDiabetes Care, 2007
- Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 studyHeart, 2006
- Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial InfarctionCirculation, 2005
- Fasting Glucose Is an Important Independent Risk Factor for 30-Day Mortality in Patients With Acute Myocardial InfarctionCirculation, 2005
- Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes MellitusArchives of internal medicine (1960), 2004
- Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarctionDiabetic Medicine, 2004
- Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarctionAmerican Heart Journal, 2003
- A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromesHeart, 2003
- Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overviewThe Lancet, 2000